RYAN GOOD: Open Payments
NPI 1104512169 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 33 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $374 · 2025 $1,428
Food & beverage: $1,183Travel & lodging: $245
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $971 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $138 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $128 |
| BridgeBio Pharma, Inc. | 2 | $46 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: WATCHMAN FLX, JARDIANCE, LifeVest, Attruby, FUROSCIX, CAMZYOS, LEQVIO, OPSYNVI.
Industry payments across MI — which companies pay providers there.
